SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-061876
Filing Date
2013-11-14
Accepted
2013-11-14 16:19:19
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v357929_10q.htm 10-Q 1813491
2 EXHIBIT 31.1 v357929_ex31-1.htm EX-31.1 27892
3 EXHIBIT 31.2 v357929_ex31-2.htm EX-31.2 8833
4 EXHIBIT 32.1 v357929_ex32-1.htm EX-32.1 4590
5 EXHIBIT 32.2 v357929_ex32-2.htm EX-32.2 5883
  Complete submission text file 0001144204-13-061876.txt   7857057

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcli-20130930.xml EX-101.INS 1087530
7 XBRL TAXONOMY EXTENSION SCHEMA bcli-20130930.xsd EX-101.SCH 70579
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20130930_cal.xml EX-101.CAL 30037
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20130930_def.xml EX-101.DEF 240727
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20130930_lab.xml EX-101.LAB 378323
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20130930_pre.xml EX-101.PRE 272794
Mailing Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158 646-666-3188
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 208133057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54365 | Film No.: 131220320
SIC: 2836 Biological Products, (No Diagnostic Substances)